Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer

Clinical Radiology

Volumn 66, Issue 12, 2011, Pages 1167-1174

  Briggs, R H ^a   Chowdhury, F U ^b   Lodge, J P A ^b   Scarsbrook, A F ^b  

^a CALDERDALE AND HUDDERSFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODIXANOL; IOVERSOL;

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CEREBELLUM TUMOR; COLON TUMOR; COLORECTAL CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INOPERABLE CANCER; LIVER METASTASIS; LUNG METASTASIS; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; METASTASIS RESECTION; METASTATIC COLORECTAL CANCER; PERITONEUM METASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; PERITONEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; UNNECESSARY PROCEDURES;

EID: 84860389389     PISSN: 00099260     EISSN: 1365229X     Source Type: Journal    
DOI: 10.1016/j.crad.2011.07.046     Document Type: Article

References (47)

1. Cancer research UK. UK bowel cancer statistics. Available at http://info.cancerresearchuk.org/cancerstats/types/bowel. [accessed 4 July 2011].
2. Office for National Statistics (ONS) Cancer statistics registrations: registrations of cancer diagnosed in 2007 2008 Office for National Statistics Newport
3. J.R. Toms Cancer stats 2007 2007 Cancer Research UK London
4. J. Scheele, R. Stang, and A. Altendorf-Hofmann Resection of colorectal liver metastases World J Surg 19 1995 59 71
5. P.E. Valk, E. Abella-Columna, and M.K. Hasemann Whole-body PET imaging with F-18 fluorodeoxyglucose in management of recurrent colorectal cancer Arch Surg 134 1999 503 513 (Pubitemid 29218121)
6. D.R. Carpizo, and M. D'Angelica Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease Lancet Oncol 10 2009 801 809
7. J.S. Tomlinson, W.R. Jamagin, and R.P. De Matteo Actual 10-year survival after resection of colorectal liver metastases defines cure J Clin Oncol 25 2007 4575 4580 (Pubitemid 350035315)
8. J.M. McLoughlin, E.H. Jensen, and M. Malafa Resection of colorectal liver metastases: current perspectives Cancer Control 13 2006 32 41 (Pubitemid 43327552)
9. Y. Fong, J. Fortner, and R.L. Sun Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 1999 309 318
10. Society for Surgery of the Alimentary Tract. Guidelines for surgery for hepatic colorectal metastases 2004. Available at: http://www.ssat.com/cgi-bin/ guidelines-HepaticColorectalMetastases-EN.cgi. [accessed 4 July 2011].
11. A.C. Ashley, C. Deschamps, and S.R. Alberts Impact of prognostic factors on clinical outcome after resection of colorectal pulmonary metastases Clin Colorectal Cancer 6 2006 32 37 (Pubitemid 44043999)
12. K.S. Hughes, R. Simon, and S. Songhorabodi Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence Surgery 100 1986 278 284 (Pubitemid 16070861)
13. A. Altendorf-Hofmann, and J. Scheele A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma Surg Oncol Clin N Am 12 2003 165 192 (Pubitemid 36210866)
14. T.M. Pawlik, R.D. Schulick, and M.A. Choti Expanding criteria for resectability of colorectal liver metastases Oncologist 13 2008 51 64 (Pubitemid 351206696)
15. D. Elias, J.F. Ouellet, and N. Bellon Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases Br J Surg 90 2003 567 574 (Pubitemid 36577888)
16. B.E. Hilner, B.A. Siegel, and D. Liu Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients in cancer; initial results from the national oncologic PET registry J Clin Oncol 26 2008 2155 2161
17. Improving outcomes in colorectal cancer. London: National Institute for Health and Clinical Excellence, 2004. Available at http://www.nice.org.uk/ nicemedia/live/10895/28833/28833.pdf. [accessed 24 July 2011].
18. A.G. Heriot, R.J. Hicks, and E.G.P.D. Drummond Does positron emission tomography change management in primary rectal cancer: a prospective assessment Dis Colon Rectum 47 2004 451 458 (Pubitemid 38436650)
19. T.J. Ruers, B.S. Langenhoff, and N. Neeleman Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study J Clin Oncol 20 2002 388 395 (Pubitemid 34072520)
20. G. Kong, C. Jackson, and M. Koh The use of 18F-FDG-PET/CT in colorectal liver metastases - comparison with CT and liver MRI Eur J Nucl Med Mol Imaging 35 2008 1323 1329
21. J.D. Soyka, P. Veit-Haibach, and K. Strobel Staging pathways in re-current colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice? J Nucl Med 49 2008 354 361 (Pubitemid 351355199)
22. T.J. Ruers, B. Wiering, and J.R. van der Sijp Improved selection of patients for hepatic surgery of colorectal liver metastases with 18F-FDG PET: a randomized study J Nucl Med 50 2009 1036 1041
23. B. Wiering, E.M. Adang, and J.R. van der Sijp Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases Nucl Med Commun 31 2010 938 944
24. T.H. Arulampalam, D.L. Francis, and D. Visvikis FDG-PET for the pre-operative evaluation of colorectal liver metastases Eur J Surg Oncol 30 2004 286 291 (Pubitemid 38425646)
25. D.C. Desai, E.E. Zervos, and M.W. Arnold Positron emission tomography affects surgical management in recurrent colorectal cancer patients Ann Surg Oncol 10 2003 59 64
26. M. Selzner, T.F. Hany, and P. Wildbrett Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240 2004 1027 1034
27. M.P. MacManus, and R.J. Hicks How can we tell if PET imaging for cancer is cost effective? Lancet Oncol 11 2010 711 712
28. A.K. Buck, K. Herrmann, and T. Stargardt Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches J Nucl Med Technol 38 2010 6 17
29. R.F. Kelly, T. Tran, and A. Holmstrom Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer Chest 125 2004 1413 1423 (Pubitemid 38501358)
30. P.E. Valk, T.R. Pounds, and R.D. Tesar Cost-effectiveness of PET imaging in clinical oncology Nucl Med Biol 23 1996 737 743 (Pubitemid 26342476)
31. C.A. de Groot, A. Senft, and R. de Bree Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients J Nucl Med 51 2010 176 182
32. M. Meister, P. Bauerfeind, and B.C. Pestalozzi Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness Ann Surg 242 2005 235 243 (Pubitemid 41033440)
33. C.K. Hoh, J. Glaspy, and P. Rosen Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma J Nucl Med 38 1997 343 348 (Pubitemid 27376879)
34. E.M. Rohren, T.G. Turkington, and R.E. Coleman Clinical applications of PET in oncology Radiology 231 2004 305 332 (Pubitemid 38552885)
35. C. Lejeune, M.J. Bismuth, and T. Conroy Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer J Nucl Med 46 2005 2020 2028 (Pubitemid 46657449)
36. K.C. Park, J. Schwimmer, and J.E. Shepherd Decision analysis for the cost- effective management of recurrent colorectal cancer Ann Surg 233 2001 310 319 (Pubitemid 32187808)
37. J.M. Zubeldia, E.M. Bednarczyk, and J.G. Baker The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases Cancer Biother Radiopharm 20 2005 450 456 (Pubitemid 41216109)
38. A.K. Buck, K. Herrmann, and T. Stargardt Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches J Nucl Med 51 2010 401 412
39. D.L. Joyce, R.L. Wahl, and P.V. Patel Preoperative positron emission tomography to evaluate potentially resectable hepatic colorectal metastases Arch Surg 141 2006 1220 1226 (Pubitemid 44956639)
40. U. Metser, E. Miller, and H. Lerman Benign non-physiologic lesions with increased 18F-FDG uptake on PET/CT: characterization and incidence AJR Am J Roentgenol 189 2007 1203 1210 (Pubitemid 350033018)
41. Y. Liu, N.V. Ghesani, and L.S. Zuckier Physiology and pathophysiology of incidental findings detected on FDG-PET scintigraphy Semin Nucl Med 40 2010 294 315
42. I.A. Zealley, S.J. Skehan, and J. Rawlinson Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG PET RadioGraphics 21 2001 S55 S69
43. E. Rappeport, A. Loft, and A. Berthelsen Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation Acta Radiol 48 2007 369 378 (Pubitemid 46633866)
44. Dushyant V. Sahani, Sanjeeva P. Kalva, and Alan J. Fischman Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET AJR Am J Roentgenol 185 2005 239 246
45. R.H. Huebner, K.C. Park, and J.E. Shepherd A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer J Nucl Med 41 2000 1177 1189 (Pubitemid 30464000)
46. K. Kitajima, K. Murakami, and E. Yamasaki Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectalcancer: comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT Eur J Nucl Med Mol Imaging 36 2009 1388 1396
47. S. Badiee, B.L. Franc, and E.M. Webb Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases AJR Am J Roentgenol 191 2008 1436 1439